Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2013 1
2014 1
2016 3
2018 1
2020 2
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
In Vivo Neuropharmacological Effects of Neophytadiene.
Gonzalez-Rivera ML, Barragan-Galvez JC, Gasca-Martínez D, Hidalgo-Figueroa S, Isiordia-Espinoza M, Alonso-Castro AJ. Gonzalez-Rivera ML, et al. Molecules. 2023 Apr 14;28(8):3457. doi: 10.3390/molecules28083457. Molecules. 2023. PMID: 37110691 Free PMC article.
Cystatin C has a dual role in post-traumatic brain injury recovery.
Martinez-Vargas M, Soto-Nuñez M, Tabla-Ramon E, Solis B, Gonzalez-Rivera R, Perez-Arredondo A, Estrada-Rojo F, Castell A, Molina-Guarneros J, Navarro L. Martinez-Vargas M, et al. Int J Mol Sci. 2014 Apr 4;15(4):5807-20. doi: 10.3390/ijms15045807. Int J Mol Sci. 2014. PMID: 24714089 Free PMC article.
Here we describe the effect of cystatin C intracerebroventricular administration in rats prior to inducing a traumatic brain injury. ...We also analyzed the expression of cathepsin B and cystatin C in the brains of control rats and of rats after a traumatic brain in …
Here we describe the effect of cystatin C intracerebroventricular administration in rats prior to inducing a traumatic brain injury. …
Neuropharmacological Activities of Ceiba aesculifolia (Kunth) Britten & Baker f (Malvaceae).
Bustos-Gómez CI, Gasca-Martínez D, Yáñez-Barrientos E, Hidalgo-Figueroa S, Gonzalez-Rivera ML, Barragan-Galvez JC, Zapata-Morales JR, Isiordia-Espinoza M, Corrales-Escobosa AR, Alonso-Castro AJ. Bustos-Gómez CI, et al. Pharmaceuticals (Basel). 2022 Dec 18;15(12):1580. doi: 10.3390/ph15121580. Pharmaceuticals (Basel). 2022. PMID: 36559031 Free PMC article.
Ceiba aesculifolia (Kunth) Britten & Baker f (Malvaceae) is used for the folk treatment of mood disorders. C. aesculifolia bark was extracted in ethanol, and the extract (CAE) was chemically standardized using gas chromatography-mass spectrometry (GC-MS). ...
Ceiba aesculifolia (Kunth) Britten & Baker f (Malvaceae) is used for the folk treatment of mood disorders. C. aesculifolia bark w …
Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients.
de Gonzalo-Calvo D, Benítez ID, Pinilla L, Carratalá A, Moncusí-Moix A, Gort-Paniello C, Molinero M, González J, Torres G, Bernal M, Pico S, Almansa R, Jorge N, Ortega A, Bustamante-Munguira E, Gómez JM, González-Rivera M, Micheloud D, Ryan P, Martinez A, Tamayo L, Aldecoa C, Ferrer R, Ceccato A, Fernández-Barat L, Motos A, Riera J, Menéndez R, Garcia-Gasulla D, Peñuelas O, Torres A, Bermejo-Martin JF, Barbé F; CIBERESUCICOVID Project (COV20/00110, ISCIII). de Gonzalo-Calvo D, et al. Transl Res. 2021 Oct;236:147-159. doi: 10.1016/j.trsl.2021.05.004. Epub 2021 May 26. Transl Res. 2021. PMID: 34048985 Free PMC article. Clinical Trial.
The discriminatory potential of the signature was higher than that observed for laboratory parameters such as leukocyte counts, C-reactive protein (CRP) or D-dimer [maximum AUC (95% CI) for these variables = 0.73 (0.55-0.92)]. miRNA levels were correlated with the duration …
The discriminatory potential of the signature was higher than that observed for laboratory parameters such as leukocyte counts, C-rea …
Neuropharmacological Effects of the Dichloromethane Extract from the Stems of Argemone ochroleuca Sweet (Papaveraceae) and Its Active Compound Dihydrosanguinarine.
Yáñez-Barrientos E, Barragan-Galvez JC, Hidalgo-Figueroa S, Reyes-Luna A, Gonzalez-Rivera ML, Cruz Cruz D, Isiordia-Espinoza MA, Deveze-Álvarez MA, Villegas Gómez C, Alonso-Castro AJ. Yáñez-Barrientos E, et al. Pharmaceuticals (Basel). 2023 Aug 18;16(8):1175. doi: 10.3390/ph16081175. Pharmaceuticals (Basel). 2023. PMID: 37631090 Free PMC article.
Structural organization of membrane-inserted hexamers formed by Helicobacter pylori VacA toxin.
Pyburn TM, Foegeding NJ, González-Rivera C, McDonald NA, Gould KL, Cover TL, Ohi MD. Pyburn TM, et al. Mol Microbiol. 2016 Oct;102(1):22-36. doi: 10.1111/mmi.13443. Epub 2016 Jul 8. Mol Microbiol. 2016. PMID: 27309820 Free PMC article.
The 88 kDa secreted VacA protein, composed of an N-terminal p33 domain and a C-terminal p55 domain, assembles into water-soluble oligomers. ...
The 88 kDa secreted VacA protein, composed of an N-terminal p33 domain and a C-terminal p55 domain, assembles into water-soluble olig …
Potential participation of cystatin C in rapid eye movement sleep (REMS) modulation.
González-Rivera R, Navarro L, Martínez-Vargas M, Guzman-Vasquez K, León-Rosario P, Landa A, Prospero-Garcia O. González-Rivera R, et al. Neurosci Lett. 2006 Nov 20;408(3):178-82. doi: 10.1016/j.neulet.2006.08.087. Epub 2006 Oct 5. Neurosci Lett. 2006. PMID: 17027151
In this context, it is important to determine the role of endogenous proteases and their endogenous inhibitors in sleep regulation. In this study, we found that Cystatin C (CC), an endogenous protease inhibitor, diminishes wakefulness and increases REMS. ...
In this context, it is important to determine the role of endogenous proteases and their endogenous inhibitors in sleep regulation. In this …
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.
Martínez-Laperche C, Buces E, Aguilera-Morillo MC, Picornell A, González-Rivera M, Lillo R, Santos N, Martín-Antonio B, Guillem V, Nieto JB, González M, de la Cámara R, Brunet S, Jiménez-Velasco A, Espigado I, Vallejo C, Sampol A, Bellón JM, Serrano D, Kwon M, Gayoso J, Balsalobre P, Urbano-Izpizua Á, Solano C, Gallardo D, Díez-Martín JL, Romo J, Buño I; GVHD/Immunotherapy Committee of the Spanish Group for Hematopoietic Transplantation. Martínez-Laperche C, et al. Blood Adv. 2018 Jul 24;2(14):1719-1737. doi: 10.1182/bloodadvances.2017011502. Blood Adv. 2018. PMID: 30030270 Free PMC article. Clinical Trial.
Models including clinical and genetic variables (CG-M) predicted severe aGVHD significantly better than models including only clinical variables (C-M) or only genetic variables (G-M). For grades 3-4 aGVHD, the correct classification rates (CCR1) were: 100% for CG-M, 88% fo …
Models including clinical and genetic variables (CG-M) predicted severe aGVHD significantly better than models including only clinical varia …
16 results